First Trust Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

First Trust Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-61,975	Closed	-$3.2M	–	2612
2022 Q3	$3.2M	Buy	61,975 +48,433	+358%	+$2M	﹤0.01%	1420
2022 Q2	$336K	Buy	+13,542	New	+$298K	﹤0.01%	2285
2021 Q2	–	Sell	-33,468	Closed	-$1.72M	–	2569
2021 Q1	$1.72M	Sell	33,468 -17,905	-35%	-$1.08M	﹤0.01%	1777
2020 Q4	$3.18M	Buy	51,373 +27,696	+117%	+$1.59M	﹤0.01%	1337
2020 Q3	$1.3M	Sell	23,677 -7,256	-23%	-$391K	﹤0.01%	1624
2020 Q2	$1.78M	Buy	+30,933	New	+$1.68M	﹤0.01%	1435

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

First Trust Advisors's CCXI Position: Q4 2022 in Review

First Trust Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 61,975 shares — an estimated $3.2M sold.

First Trust Advisors first reported a position in CCXI in Q2 2020 and held it in 6 quarters. The position peaked at $3.2M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

First Trust Advisors reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
First Trust Advisors sold 61,975 ChemoCentryx, Inc. shares in Q4 2022, an estimated $3.2M.
First Trust Advisors first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 6 quarters.
First Trust Advisors's ChemoCentryx, Inc. position peaked at $3.2M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on First Trust Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.